BBNX logo
NASDAQ · BBNXMedical - DevicesUpdated Nov 4, 2026

Beta Bionics, Inc. ROE

Profitability, historical returns, and peer comparisons.

The ROE as of November 2026 (TTM) for Beta Bionics, Inc. (BBNX) is -27.33%

According to Beta Bionics, Inc.’s latest financial reports and current stock price. The company's current ROE is -27.33%. This represents a change of 291.09% compared to the average of -6.99% of the last 4 quarters.

Beta Bionics, Inc. (BBNX) Historical ROE (quarterly & annually)

How has BBNX ROE performed in the past?

The mean historical ROE of Beta Bionics, Inc. over the last ten years is -33.66%. The current -27.33% ROE has changed -18.82% with respect to the historical average. Over the past ten years (40 quarters), BBNX's ROE was at its highest in in the September 2023 quarter at 0%. The ROE was at its lowest in in the December 2023 quarter at -32.16%.

Quarterly (TTM)
Annual

Average

-33.66%

Median

-48.74%

Minimum

-75.24%

Maximum

38.08%

Beta Bionics, Inc. (BBNX) ROE by Quarter and Year

Discovering the peaks and valleys of Beta Bionics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual ROE = 38.08%

Minimum Annual Increase = -297.59%

Minimum Annual ROE = -75.24%

Quarterly (TTM)
Annual
YearROEChange
2025-25.45%-64.67%
2024-72.04%-4.26%
2023-75.24%-297.59%

Beta Bionics, Inc. (BBNX) Average ROE

How has BBNX ROE performed in the past?

The current ROE of Beta Bionics, Inc. (BBNX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-57.58%

5-year avg

-33.66%

10-year avg

-33.66%

Beta Bionics, Inc. (BBNX) ROE vs. Peers

How is BBNX’s ROE compared to its peers?

Beta Bionics, Inc.’s ROE is less than Insulet Corp. (29.48%), greater than Tandem Diabetes Care, Inc. (-45.97%), less than DexCom, Inc. (36.50%), greater than MiniMed Group, Inc. (-9.11%), less than Novo Nordisk A/S (59.09%), less than MannKind Corporation (78.60%), less than Oramed Pharmaceuticals Inc. (72.96%),

Build a custom stock screener for Beta Bionics, Inc. (BBNX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Beta Bionics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Beta Bionics, Inc. (BBNX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Beta Bionics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Beta Bionics, Inc.'s ROE?

How is the ROE calculated for Beta Bionics, Inc. (BBNX)?

What is the highest ROE for Beta Bionics, Inc. (BBNX)?

What is the 3-year average ROE for Beta Bionics, Inc. (BBNX)?

What is the 5-year average ROE for Beta Bionics, Inc. (BBNX)?

How does the current ROE for Beta Bionics, Inc. (BBNX) compare to its historical average?